Clinical Trial Update: GORE® Septal Occluder European Union Clinical Evaluation [NA]

View source ↗

Summary

The EU clinical evaluation for the GORE Septal Occluder has completed. The trial evaluated closure of patent foramen ovale.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Foramen Ovale

Drugs mentioned

• GORE Septal Occluder (Septal occluder device)

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Closure; Foramen Ovale | NA | Status: COMPLETED